Carisma Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Revenue	14.92	9.83	26.54	11.24	0	0	0.43	29.98	0.99	2.24	Upgrade
Revenue Growth (YoY)	51.71%	-62.95%	136.24%	-	-	-	-98.58%	2928.38%	-55.86%	68.14%	Upgrade
Gross Profit	14.92	9.83	26.54	11.24	0	0	0.43	29.98	0.99	2.24	Upgrade
Selling, General & Admin	29.53	9.38	29.39	14.3	12.21	11.62	8.07	14.74	9.85	8.47	Upgrade
Research & Development	74.13	56.62	25.31	29.19	24.66	14.08	12.51	13.48	26.34	26.7	Upgrade
Other Operating Expenses	0	0	37.23	0	0	0	0	0	0	0	Upgrade
Operating Expenses	103.65	66	91.93	43.49	36.87	25.7	20.58	28.22	36.19	35.17	Upgrade
Operating Income	-88.73	-56.16	-65.39	-32.26	-36.87	-25.7	-20.16	1.77	-35.2	-32.93	Upgrade
Interest Expense / Income	-1.94	3.15	0	0	0	0	0	0.25	1.4	0.38	Upgrade
Other Expense / Income	0.08	1.92	-56.78	-11.31	70.63	7.99	8.87	-0.38	-3.14	0.85	Upgrade
Pretax Income	-86.88	-61.23	-8.61	-20.95	-107.5	-33.69	-29.03	1.9	-33.45	-34.16	Upgrade
Income Tax	0	0	-8.27	1.45	0	0	0	0.01	0	0	Upgrade
Net Income	-86.88	-61.23	-0.34	-22.4	-107.5	-33.69	-29.03	1.89	-33.45	-34.16	Upgrade
Preferred Dividends	0	0	0	0.15	0	0	0	0	0	0.52	Upgrade
Net Income Common	-86.88	-61.23	-0.34	-22.54	-107.5	-33.69	-29.03	1.89	-33.45	-34.68	Upgrade
Shares Outstanding (Basic)	34	2	9	6	5	3	1	1	1	1	Upgrade
Shares Outstanding (Diluted)	34	2	9	6	5	3	1	1	1	1	Upgrade
Shares Change	1475.33%	-76.66%	54.22%	30.01%	47.20%	136.64%	20.12%	14.43%	29.70%	983.14%	Upgrade
EPS (Basic)	-2.59	-28.77	-	-3.80	-23.60	-11.00	-22.20	1.80	-35.20	-47.40	Upgrade
EPS (Diluted)	-2.59	-28.77	-	-3.80	-23.60	-11.00	-22.20	1.80	-35.20	-47.40	Upgrade
Free Cash Flow	-82.31	-9.78	-68.88	-30.85	-37.66	-22.83	-17.67	2.86	-34.82	-29.44	Upgrade
Free Cash Flow Per Share	-2.46	-4.59	-7.56	-5.22	-8.28	-7.39	-13.54	2.72	-36.66	-40.21	Upgrade
Dividend Per Share	0.361	-	-	-	-	-	-	-	-	-	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-594.75%	-571.10%	-246.34%	-287.09%	-	-	-4742.35%	5.89%	-3555.15%	-1468.17%	Upgrade
Profit Margin	-582.34%	-622.60%	-1.27%	-200.64%	-	-	-6830.35%	6.31%	-3378.99%	-1545.92%	Upgrade
Free Cash Flow Margin	-551.71%	-99.41%	-259.50%	-274.52%	-	-	-4156.94%	9.55%	-3516.77%	-1312.71%	Upgrade
Effective Tax Rate	-	-	-	-	-	-	-	0.26%	-	-	Upgrade
EBITDA	-80.55	-51.99	-8.52	-20.83	-107.28	-33.49	-28.74	2.32	-31.69	-33.37	Upgrade
EBITDA Margin	-539.92%	-528.69%	-32.11%	-185.39%	-	-	-6763.29%	7.74%	-3201.11%	-1487.74%	Upgrade
Depreciation & Amortization	8.27	6.09	0.09	0.12	0.22	0.21	0.29	0.18	0.37	0.41	Upgrade
EBIT	-88.82	-58.08	-8.61	-20.95	-107.5	-33.69	-29.03	2.14	-32.06	-33.78	Upgrade
EBIT Margin	-595.31%	-590.61%	-32.43%	-186.47%	-	-	-6830.35%	7.15%	-3238.08%	-1506.02%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).